Bessemer Group’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Bessemer Group’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-435	Closed	-$138K	–	2244
2023 Q4	$138K	Buy	435 +79	+22%	+$15.4K	﹤0.01%	1135
2023 Q3	$60K	Hold	356	–	–	﹤0.01%	1312
2023 Q2	$77K	Hold	356	–	–	﹤0.01%	1292
2023 Q1	$65K	Buy	+356	New	+$68.1K	﹤0.01%	1169

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Bessemer Group's KRTX Position: Q1 2024 in Review

Bessemer Group sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 435 shares — an estimated $138K sold.

Bessemer Group first reported a position in KRTX in Q1 2023 and held it in 4 quarters. The position peaked at $138K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Bessemer Group reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Bessemer Group sold 435 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $138K.
Bessemer Group first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2023 and held it in 4 quarters.
Bessemer Group's Karuna Therapeutics, Inc. Common Stock position peaked at $138K in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Bessemer Group's 13F filing for Q1 2024, filed 13 May 2024.